or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    CLDX F Celldex Therapeutics, Inc. -0.68
    IPHA D Innate Pharma S.A. 0.86
    PYXS D Pyxis Oncology, Inc. -45.03
    OTLK D Outlook Therapeutics, Inc. -2.84
    MRKR D Marker Therapeutics, Inc. -7.18
    CASI D CASI Pharmaceuticals, Inc. -0.19
    PSTX D Poseida Therapeutics, Inc. -0.37
    SLS D SELLAS Life Sciences Group, Inc. -1.61
    REPL D Replimune Group, Inc. -1.60
    IBRX C ImmunityBio, Inc. 3.28
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Solid Tumors Biotechnology Clinical Medicine Immune System Immunotherapy Biopharmaceutical Immunology Monoclonal Antibody Ovarian Cancer Immunotherapies Life Sciences Monoclonal Antibodies Treatment Of Cancer Virotherapy Acute Myeloid Leukemia Antibodies Antibody Drug Conjugate Antineoplastic Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.54
    SBIO C ALPS Medical Breakthroughs ETF 1.56
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.55
    CANC D Tema Oncology ETF 1.44
    MEDX F Horizon Kinetics Medical ETF 0.98
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare CNCR to CANC Compare CNCR to MEDX Compare CNCR to SBIO

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Nov 21 REPL Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
        Nov 21 PYXS Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 PYXS Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade
        Nov 21 IBRX ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment
        Nov 20 PYXS Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
        Nov 20 PYXS Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
        Nov 20 IBRX High Growth Tech Stocks To Watch In November 2024
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 20 IPHA Innate Pharma Releases Its 2025 Financial Calendar
        Nov 19 IBRX ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months
        Nov 19 IPHA Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
        Nov 17 MRKR Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 CASI CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 SLS We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate
        Nov 15 CASI CASI Pharmaceuticals reports Q3 results
        Nov 15 CASI CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Solid Tumors Biotechnology Clinical Medicine Immune System Immunotherapy Biopharmaceutical Immunology Monoclonal Antibody Ovarian Cancer Immunotherapies Life Sciences Monoclonal Antibodies Treatment Of Cancer Virotherapy Acute Myeloid Leukemia Antibodies Antibody Drug Conjugate Antineoplastic Drugs
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags